4-氯甲基-1,2-二乙氧基苯 | 27472-20-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氯甲基-1,2-二乙氧基苯
• 英文名称: 3,4-diethoxybenzyl chloride
• 英文别名: 4-(chloromethyl)-1,2-diethoxybenzene；1,2-diethoxy-4-chloromethyl-benzene；1,2-Diaethoxy-4-chlormethyl-benzol；4-Chloromethyl-1,2-diethoxy-benzene
• CAS: 27472-20-4
• 化学式: C₁₁H₁₅ClO₂
• mdl: MFCD03988543
• 分子量: 214.692
• InChiKey: TXBSWQWDLFJQMU-UHFFFAOYSA-N

物化性质

• 熔点：
  126-127 °C
• 沸点：
  294.4±25.0 °C(Predicted)
• 密度：
  1.083±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2909309090

反应信息

• 作为反应物：
  描述：

  4-氯甲基-1,2-二乙氧基苯 在 sodium hydride 、 sodium amide 作用下， 以 水 、 苯 为溶剂， 反应 11.17h， 生成 methyl 2-cyano-2-(3,4-diethoxyphenyl) propionate
  参考文献：
  名称：

  Enzymes in organic synthesis 51. Probing the dimensions of the large hydrophobic pocket of the active site of pig liver esterase

  摘要：

  The dimensions of the large hydrophobic pocket (H(L)) of the active site model of pig liver esterase (PLE) were probed using a series of aliphatic and phenylic malonates. Results from the hydrolyses of these new unnatural substrates permitted the extension of the H(L) pocket to give the new dimensions of 6.2 x 2.3 x 3.9 angstrom for a total volume of approximately 56 angstrom3.

  DOI：

  10.1016/s0957-4166(00)82251-x
• 作为产物：
  描述：

  3,4-二乙氧基苯甲醇 在 吡啶 、 氯化亚砜 作用下， 以 四氢呋喃 为溶剂， 反应 8.0h， 以97%的产率得到4-氯甲基-1,2-二乙氧基苯
  参考文献：
  名称：

  Stilbenoid衍生物作为强大的血管松弛药的体外研究和结构-活性关系分析：发现新的铅化合物

  摘要：

  血管舒张剂作为抗高血压药的发展很重要，因为它对血管肌肉产生快速直接的松弛作用。白藜芦醇（RV），作为最广泛研究的类雌二醇和先导化合物，通过多种信号途径诱导优异的血管舒张作用。在这项研究中，主要通过使用去氧肾上腺素（PE）预收缩的内皮完整分离的主动脉环来评估合成的反式-类类植物衍生物SB 1-8e的体外血管反应。本文中我们报道了反式-3,4,4'-三羟基sti （SB 8b）的最大弛豫（RRV的最大值）。本文还重点介绍了在1 H NMR中芳香族质子的独特裂解方式。

  DOI：

  10.1016/j.bioorg.2020.104239

文献信息

• SUBSTITUTED TRICYCLIC ACID DERIVATIVES AS S1P1 RECEPTOR AGONISTS USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
  申请人：Jones Robert M.

  公开号：US20110160243A1

  公开（公告）日：2011-06-30

  The present invention relates to certain substituted tricyclic acid derivatives of Formula (I) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1-associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, myocardial ischemia-reperfusion injury, hypertensive nephropathy, glomerulosclerosis, gastritis, polymyositis, thyroiditis, vitiligo, hepatitis, biliary cirrhosis, microbial infections and associated diseases, viral infections and associated diseases, diseases and disorders mediated by lymphocytes, auto immune diseases, inflammatory diseases, and cancer.

  本发明涉及某些取代的三环酸衍生物，其具有式(I)和药用可接受的盐，并表现出有用的药理性质，例如，作为S1P1受体的激动剂。本发明还提供了含有发明的化合物的药物组合物，以及使用发明中的化合物和组合物治疗与S1P1相关的疾病的方法，例如，银屑病、类风湿性关节炎、克罗恩病、移植排斥反应、多发性硬化症、系统性红斑狼疮、溃疡性结肠炎、I型糖尿病、痤疮、心肌缺血再灌注损伤、高血压肾病、肾小球硬化症、胃炎、多发性肌炎、甲状腺炎、白癜风、肝炎、胆汁性肝硬化、微生物感染及相关疾病、病毒感染及相关疾病、由淋巴细胞介导的疾病和障碍、自身免疫性疾病、炎症性疾病和癌症。
• Cyclic compounds and uses thereof
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US06627651B1

  公开（公告）日：2003-09-30

  Compounds of general formula (1) R1—X1—W—X2—Z1—Z2—R2 or salts thereof, exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group represented by, e. g., general formula (2) (wherein A and B are each an optionally substituted five- to seven-membered ring; E1 and E4 are each optionally substituted carbon or the like; E2 and E3 are each oxygen or the like; and a and b are each a single bond or a double bond); X2 is a divalent group constituting a straight chain moiety; Z1 is a divalent cyclic group or the like; Z2 is a free valency or the like; and R2 is optionally substituted amino or the like.

  一般公式（1）的化合物 R1—X1—W—X2—Z1—Z2—R2 或其盐，具有预防治疗HIV传染性疾病的作用，其中R1是可选地取代的五至六元环基团；X1是自由价电子或类似物；W是二价基团，例如，由一般公式（2）表示 （其中A和B各自是可选地取代的五至七元环；E1和E4各自是可选地取代的碳或类似物；E2和E3各自是氧或类似物；a和b各自是单键或双键）；X2是构成直链部分的二价基团；Z1是二价环状基团或类似物；Z2是自由价电子或类似物；R2是可选地取代的氨基或类似物。
• New Acyl Derivatives of 3-Aminofurazanes and Their Antiplasmodial Activities
  作者：Theresa Hermann、Patrick Hochegger、Johanna Dolensky、Werner Seebacher、Robert Saf、Marcel Kaiser、Pascal Mäser、Robert Weis

  DOI：10.3390/ph14050412

  日期：——

  shown activity against different strains of Plasmodium falciparum. Seventeen new derivatives were prepared and tested in vitro for their activities against blood stages of two strains of Plasmodium falciparum. Several structure–activity relationships were revealed. The activity strongly depended on the nature of the acyl moiety. Only benzamides showed promising activity. The substitution pattern of their

  一项针对疟疾的药物风险投资（MMV）项目的N-酰化呋喃3胺已显示出对不同菌株恶性疟原虫的活性。制备了17种新的衍生物，并在体外测试了它们对两株恶性疟原虫血液阶段的活性。揭示了几种构效关系。活性强烈取决于酰基部分的性质。仅苯甲酰胺显示出有希望的活性。它们的苯环的取代方式影响化合物的活性和细胞毒性。另外，通过PAMPA计算（log P，log D，配体效率）或通过实验确定其物理化学参数（渗透率）。该ñ-（4-（3,4-二乙氧基苯基）-1,2,5-恶二唑-3-基）-3-（三氟甲基）苯甲酰胺具有良好的理化性质，对氯喹敏感菌株具有很高的抗血浆活性（IC 50（ NF54）= 0.019 µM）甚至更高的抗多重耐药菌株的抗疟原虫活性（IC 50（K 1）= 0.007 µM）。与MMV化合物相比，提高了通透性和抗多抗性菌株的活性。
• METHOD FOR PRODUCING A HIGH-PURITY AROMATIC METHYL ALCOHOL AND HIGH-PURITY AROMATIC METHYL ALCOHOL COMPOSITION HAVING EXCELLENT PRESERVATION STABILITY
  申请人：Doi Takashi

  公开号：US20120323021A1

  公开（公告）日：2012-12-20

  An object of the present invention is to provide a high-purity aromatic methyl alcohol compound having reduced a bis(arylmethyl)ether compound as a side product mixed thereinto and a high-purity aromatic methyl alcohol composition having excellent preservation stability and methods for producing them. The object of the present invention is achieved by a method for producing a high-purity aromatic methyl alcohol compound, which comprises obtaining a high-purity aromatic methyl alcohol compound in high yield from an aromatic methyl alcohol-containing crude product by subjecting the crude product to distillation in the presence of an anti-decomposition agent. Further, the object for the preservation stability is achieved by producing a high-purity aromatic methyl alcohol composition using the obtained high-purity aromatic methyl alcohol compound.

  本发明的目的是提供一种高纯度芳香基甲醇化合物，其中混有减少的双(芳基甲基)醚化合物作为副产物，并且具有良好的保存稳定性的高纯度芳香基甲醇组合物及其生产方法。本发明的目的通过以下方法实现：通过在抗分解剂的存在下对含芳香基甲醇的原始产品进行蒸馏，从而高产率地获得高纯度芳香基甲醇化合物。此外，通过使用获得的高纯度芳香基甲醇化合物生产高纯度芳香基甲醇组合物，实现了保存稳定性的目标。
• Thiazolidine derivatives use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US04376777A1

  公开（公告）日：1983-03-15

  A thiazolidine derivative of the formula: ##STR1## wherein R.sub.1 is hydrogen, hydroxyl, lower alkyl having 1 to 4 carbon atoms, lower alkoxy having 1 to 4 carbon atoms, or lower carboxylic acyloxy having 2 to 4 carbon atoms; each of R.sub.2 and R.sub.3 is hydroxyl, lower alkyl having 1 to 4 carbon atoms, lower alkoxy having 1 to 4 carbon atoms or lower carboxylic acyloxy having 2 to 4 carbon atoms or pharmaceutically acceptable salt thereof a is a novel compound having antiulcer activity and inhibitory effect on gastric acid secretion. The compound is useful as antiulcer agent or inhibitory agent of gastric acid secretion.

  一种噻唑啉衍生物，其化学式为：##STR1## 其中R.sub.1是氢，羟基，1到4个碳原子的低级烷基，1到4个碳原子的低级烷氧基或2到4个碳原子的低级羧酸酰氧基；R.sub.2和R.sub.3中的每一个是羟基，1到4个碳原子的低级烷基，1到4个碳原子的低级烷氧基或2到4个碳原子的低级羧酸酰氧基，或其药学上可接受的盐，是一种具有抗溃疡活性和抑制胃酸分泌作用的新化合物。该化合物可用作抗溃疡剂或胃酸分泌抑制剂。